Novome Biotechnologies
Engineering Living Medicines for Chronic Diseases
1 employees · est. 2016 · South San Francisco, United...
Novome Biotechnologies is the older company (2017 vs 2016); MicroByre is the larger of the two.
Side-by-Side Comparison
| Metric | MicroByre | Novome Biotechnologies |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2016 older |
| Headquarters | ||
| Headquarters | Berkeley, United States | South San Francisco, United States |
| Employees | ||
| Employees | 33 larger | 1 |
| Industry | ||
| Industry | Biotechnology, Clean Energy | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Series B |
| Total Funding | ||
| Total Funding | $12.87M | $82.84M |
| Funding Rounds | ||
| Funding Rounds | 6 | 5 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Synthetic Biology, Bioengineering, Microbiology, Molecular Biology, Computational Biology, Genetics, Bacterial Engineering, Renewable Biomass, Industrial Biotechnology, Bioprocessing, Genetic Modification, Characterization Pipeline, Biomass Conversion, Biotechnology Innovation, Eco-Friendly Solutions | Genetically Engineered Microbial Medicines, GEMMs Platform, Chronic Disease Treatment, Gut Microbiota Engineering, Controlled Colonization, Microbial Cell Therapy, Phase 2 Clinical Trials, Enteric Hyperoxaluria, Inflammatory Bowel Disease, Biotechnology Company, Synthetic Biology Platform, Therapeutic Bacteria, Oxalate Degradation, Kidney Stone Prevention, Living Therapeutics |
| Website | ||
| Website | microbyre.com | novomebio.com |
About MicroByre
MicroByre, a cutting-edge player in the Biotechnology and Clean Energy sectors, was founded in 2017 and is headquartered in the United States. The company stands out with its unique approach: domesticating and genetically engineering non-cultivable bacteria to replace petrochemicals with renewable b...
About Novome Biotechnologies
Novome Biotechnologies, founded in 2016, is pioneering the development of genetically engineered microbial medicines, known as GEMMs, aimed at effectively treating chronic diseases through the human gut. Under the informative slogan, "Engineering Living Medicines for Chronic Diseases," the company h...
We will tell you when either one moves
BounceWatch watches MicroByre and Novome Biotechnologies for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MicroByre and Novome Biotechnologies — by email.
Frequently Asked Questions
Compare MicroByre with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at MicroByre on 26 Jul 2024, and Novome Biotechnologies on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.